Preclinical immunological evaluation of an intradermal heterologous vaccine against SARS-CoV-2 variants

The recent emergence of COVID-19 variants has necessitated the development of new vaccines that stimulate the formation of high levels of neutralizing antibodies against S antigen variants. A new strategy involves the intradermal administration of heterologous vaccines composed of one or two doses o...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Shengtao, Xiao, Kang, Li, Dandan, Zhao, Heng, Zhang, Jingjing, Yu, Li, Chang, Penglan, Zhu, Shuangli, Xu, Xingli, Liao, Yun, Ji, Tianjiao, Jiang, Guorun, Yan, Dongmei, Zeng, Fengyuan, Duan, Suqin, Xia, Baicheng, Wang, Lichun, Yang, Fengmei, He, Zhanlong, Song, Yang, Cui, Pingfang, Li, Xiaolei, Zhang, Yaxing, Zheng, Bangyi, Zhang, Ying, Xu, Wenbo, Li, Qihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745378/
https://www.ncbi.nlm.nih.gov/pubmed/34931939
http://dx.doi.org/10.1080/22221751.2021.2021807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745378/
https://www.ncbi.nlm.nih.gov/pubmed/34931939
http://dx.doi.org/10.1080/22221751.2021.2021807

Ejemplares similares